Kit Box Character Contest  Make your EpiGentek box “alive” and win a $1500 grant for antibodies plus more! » Learn More
Epigentek Home
 
EpiGentek Guarantee

EYA4 Polyclonal Antibody, FITC Conjugated

Share:

Write a Review
Application: ELISA
Areas of Research: Cell Development & Differentiation
Clonality: Polyclonal
Conjugate: FITC
Host: Rabbit
Isotype: IgG
Purification: Protein G Purified
Reactivity: Human
100% Guarantee: 6 months
Catalog No.SizePriceQty
A69493-05050 µg $249.00 
A69493-100100 µg $399.00 
Why EpiGentek AntibodiesFree Shipping on Antibodies
Order now & get it by Tuesday, September 10th  
Product Overview

Background
Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organogenesis. May be involved in development of the eye.

Description
EYA4 Polyclonal Antibody, FITC Conjugated. FITC. Raised in: Rabbit.

Formulation
Liquid. 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4.

Specificity
Human

Isotype
IgG

Uniprot ID
O95677

Purification
>95%, Protein G purified

Immunogen
Recombinant Human Eyes absent homolog 4 protein (153-224AA)

Storage
Shipped at 4°C. Upon receipt, store at -20°C (short-term) or -80°C (long-term). Avoid repeated freeze.

Alternative Names
Eyes absent homolog 4, EYA4

Application
ELISA

User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

Phone Wallet and Stand Give-a-way
Terms & Conditions | Privacy Policy | Site Map
Copyright © 2019 EpiGentek Group Inc. All rights reserved.